Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens

被引:1
作者
Imani, Saber [1 ]
Lv, Shuojie [1 ]
Qian, Hongbo [1 ]
Cui, Yulan [1 ]
Li, Xiaoyan [1 ]
Babaeizad, Ali [2 ]
Wang, Qingjing [1 ]
机构
[1] Zhejiang Shuren Univ, Shulan Int Med Coll, Key Lab Artificial Organs & Computat Med Zhejiang, Key Lab Pollut Exposure & Hlth Intervent Zhejiang, Hangzhou 310015, Zhejiang, Peoples R China
[2] Semnan Univ Med Sci, Fac Med, Semnan, Iran
关键词
mRNA vaccines; Multidrug-resistant; ESKAPE pathogens; Antigen selection; mRNA vaccine technology; CAPSULAR POLYSACCHARIDE VACCINE; ENTEROCOCCAL SURFACE PROTEIN; OUTER-MEMBRANE PROTEINS; III SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; MOLECULAR-DETECTION; CANDIDATE VACCINE; VIRULENCE FACTORS;
D O I
10.1016/j.biotechadv.2024.108492
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The prevalence of multidrug-resistant (MDR) ESKAPE pathogens, including Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, represents a critical global public health challenge. In response, mRNA vaccines offer an adaptable and scalable platform for immunotherapy against ESKAPE pathogens by encoding specific antigens that stimulate B-cell-driven antibody production and CD8+ T-cell-mediated cytotoxicity, effectively neutralizing these pathogens and combating resistance. This review examines recent advancements and ongoing challenges in the development of mRNA vaccines targeting MDR ESKAPE pathogens. We explore antigen selection, the nuances of mRNA vaccine technology, and the complex interactions between bacterial infections and antibiotic resistance. By assessing the potential efficacy of mRNA vaccines and addressing key barriers to their paraclinical implementation, this review highlights the promising function of mRNA-based immunization in combating MDR ESKAPE pathogens.
引用
收藏
页数:21
相关论文
共 261 条
[81]   Staphylococcus aureus host interactions and adaptation [J].
Howden, Benjamin P. ;
Giulieri, Stefano G. ;
Lung, Tania Wong Fok ;
Baines, Sarah L. ;
Sharkey, Liam K. ;
Lee, Jean Y. H. ;
Hachani, Abderrahman ;
Monk, Ian R. ;
Stinear, Timothy P. .
NATURE REVIEWS MICROBIOLOGY, 2023, 21 (06) :380-395
[82]   Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models [J].
Huang, Weiwei ;
Yao, Yufeng ;
Long, Qiong ;
Yang, Xu ;
Sun, Wenjia ;
Liu, Cunbao ;
Jin, Xiaomei ;
Li, Yang ;
Chu, Xiaojie ;
Chen, Bin ;
Ma, Yanbing .
PLOS ONE, 2014, 9 (06)
[83]   Contribution of Mucoviscosity-Associated Gene A (magA) to Virulence in Experimental Klebsiella pneumoniae Endophthalmitis [J].
Hunt, Jonathan J. ;
Wang, Jin-Town ;
Callegan, Michelle C. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (09) :6860-6866
[84]   Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities [J].
Husna, Asmaul ;
Rahman, Md. Masudur ;
Badruzzaman, A. T. M. ;
Sikder, Mahmudul Hasan ;
Islam, Mohammad Rafiqul ;
Rahman, Md. Tanvir ;
Alam, Jahangir ;
Ashour, Hossam M. .
BIOMEDICINES, 2023, 11 (11)
[85]   The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus [J].
Jahantigh, Hamid Reza ;
Faezi, Sobhan ;
Habibi, Mehri ;
Mahdavi, Mehdi ;
Stufano, Angela ;
Lovreglio, Piero ;
Ahmadi, Khadijeh .
VACCINES, 2022, 10 (02)
[86]   α-hemolysin of Staphylococcus aureus impairs thrombus formation [J].
Jahn, Kristin ;
Handtke, Stefan ;
Palankar, Raghavendra ;
Kohler, Thomas P. ;
Wesche, Jan ;
Wolff, Martina ;
Bayer, Janina ;
Wolz, Christiane ;
Greinacher, Andreas ;
Hammerschmidt, Sven .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (06) :1464-1475
[87]   The impact of human vaccines on bacterial antimicrobial resistance. A review [J].
Jansen, Kathrin U. ;
Gruber, William C. ;
Simon, Raphael ;
Wassil, James ;
Anderson, Annaliesa S. .
ENVIRONMENTAL CHEMISTRY LETTERS, 2021, 19 (06) :4031-4062
[88]   FURTHER APPROACHES FOR OPTIMIZING POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES FOR PREVENTION OF INVASIVE BACTERIAL DISEASE [J].
JENNINGS, H .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 :S156-S159
[89]   Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii [J].
Jo, Jeongwoo ;
Ko, Kwan Soo .
MICROBIOLOGY SPECTRUM, 2021, 9 (02)
[90]  
JUNG F, 1978, Z PSYCHOSOM MED PSYC, V24, P36